Cubist Pharmaceuticals, Inc. (CBST)

[surf1944]

9:05AM Cubist Pharma unveils Five-Year strategic goals (CBST) 41.35 : Co announces five-year strategic aspirations at its Investor Da. In summary, by year-end 2017, co expects to: (-) Grow global revenue to $2 bln annually; (-) Have four product candidates in late-stage clinical trials; (-) Generate $700 mln in non-GAAP annual adjusted operating income; and (-) Continue to strengthen and develop the co's highly differentiated culture.